Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BrainCase is a specialized biotechnology company focused on the development and manufacturing of viral vectors for neuroscience research and gene therapy. The company provides a robust platform for the production of high-quality viral tools, including AAV, lentivirus, rabies virus, and pseudorabies virus, which are essential for mapping neural circuits and delivering genetic material. Operating as both a CRO and CDMO, BrainCase supports academic researchers and pharmaceutical companies in their efforts to understand brain function and develop treatments for CNS disorders. Their services span from early-stage research tool provision to clinical-grade vector production. The company is headquartered in Shenzhen, China, and leverages advanced expertise in virology and neurobiology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BrainCase.